Gatifloxacin
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), Innovative Medical, Stanford University, Walter Reed Army Medical Center, Allergan
Conditions
Bacterial ConjunctivitisCataract ExtractionCataract SurgeryEnteric FeverEpithelium, CornealHealthyInjectionsIntravitreous
Phase 1
Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
CompletedNCT00396084
Start: 2004-02-10End: 2007-12-28Updated: 2018-11-08
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
CompletedNCT00824070
Start: 2009-02-28End: 2009-08-31Updated: 2011-12-13
Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation
CompletedNCT00905762
Start: 2009-03-31End: 2009-04-30Updated: 2011-12-09
Phase 3
Phase 4
Therapeutic Variables in Cataract Surgery
CompletedNCT00407017
Updated: 2007-08-21
Topical Antibiotics and Intravitreous Injections
CompletedNCT00410891
Start: 2008-07-31End: 2009-12-31Updated: 2017-11-06
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis
CompletedNCT00464438
Start: 2007-06-30End: 2008-09-30Updated: 2011-09-21
Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever
CompletedNCT01421693
Start: 2011-09-30End: 2015-01-31Updated: 2016-10-04